Open access · CC-BY
via OpenAlex
Pharmacological Activation of Mitophagy Confers Neuroprotective Benefits for Amyotrophic Lateral Sclerosis
Sen Huang, Ang Li, Yixia Ling, Xinyu Yang, Jiayu Wang, Jing Yuan, Dajiang Qin, Xiaoli Yao
Aging and Disease · 2025 · ▲ 1 citations
Abstract
Amyotrophic lateral sclerosis (ALS) is a rare and devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons in the brain and spinal cord, for which no cure currently exists. Previous studies have shown that abnormal mitochondrial homeostasis and defective mitophagy occur in neurodegenerative diseases, including ALS. Here, we provide evidence that PINK1-Parkin-dependent mitophagy is impaired in multiple ALS mouse models, including the SOD1G93A, TDP43A315T, and rNLS8 strains, leading to the accumulation of damaged mitochondria in affected motor neurons. These findings suggest that mitophagy may be a druggable target for ALS treatment. A classical mitophagy agonist, urolithin A (UA) was used in this study. UA-induced mitophagy antagonizes ALS pathologies in the ALS SOD1G93A transgenic C. elegans model in a pink-1 (PTEN-induced kinase 1)- and pdr-1 (Parkinson’s disease-related 1)-dependent manner. Furthermore, pharmacological activation of mitophagy by UA improves locomotor behavior, delays motor neuron degeneration and reduces neuroinflammation in ALS SOD1G93A transgenic mice. In conclusion, our results establish impaired mitophagy as a hallmark of ALS motor neuron degeneration and demonstrate that its pharmacological activation offers a neuroprotective strategy with therapeutic potential.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.14336/ad.2025.1224
- Canonical
- link ↗
- Fetched
- 2026-10-11 MST
Cite this
APA
Huang, S., Li, A., Ling, Y., Yang, X., Wang, J., Yuan, J., Qin, D., & Yao, X. (2025). Pharmacological Activation of Mitophagy Confers Neuroprotective Benefits for Amyotrophic Lateral Sclerosis. <em>Aging and Disease</em>. https://doi.org/10.14336/ad.2025.1224
Vancouver
Huang S, Li A, Ling Y, Yang X, Wang J, Yuan J, et al. Pharmacological Activation of Mitophagy Confers Neuroprotective Benefits for Amyotrophic Lateral Sclerosis. Aging and Disease. 2025. doi:10.14336/ad.2025.1224.
BibTeX
@article{sen2025Pharma,
title = {Pharmacological Activation of Mitophagy Confers Neuroprotective Benefits for Amyotrophic Lateral Sclerosis},
author = {Sen Huang and Ang Li and Yixia Ling and Xinyu Yang and Jiayu Wang and Jing Yuan and Dajiang Qin and Xiaoli Yao},
journal = {Aging and Disease},
year = {2025},
doi = {10.14336/ad.2025.1224},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Molecular Neuroscience 2022
Open access · CC-BY
Role of mitophagy in the neurodegenerative diseases and its pharmacological advances: A review
Autophagy 2024
Open access · CC-BY
Poly-GP accumulation due to C9orf72 loss of function induces motor neuron apoptosis through autophagy and mitophagy defects
Biology Direct 2023
Open access · CC-BY
Quinolinic acid impairs mitophagy promoting microglia senescence and poor healthspan in C. elegans: a mechanism of impaired aging process
OSF Preprints (OSF Preprints) 2023
Preprint · CC-BY
Mitophagy enhancers as therapeutic targets for neuroprotection against amyloid-beta plaque and neurofibrillary tangle accumulation in Alzheimer’s patients
npj Aging 2026
Open access · CC-BY
Targeting mitophagy for neuroprotection: mechanisms and therapeutic opportunities
PLoS ONE 2014
Open access · CC-BY